The evidence is weak, but not empty. Two small human pilots reported changes in tone or instrument readings after using named Kumkumadi preparations. Neither had a convincing control group, and neither can tell us whether saffron, the base oil, massage, cleansing or another herb caused the change (Kulangara et al., 2026; Maneesha et al., 2025).

The narrowest defensible expectation is a possible short-term change in selected measured tone or redness endpoints in a similar preparation (Kulangara et al., 2026; Maneesha et al., 2025). Neither pilot establishes a sensory benefit, and “treats pigmentation” is a different claim that these studies do not support.

What the newer instrument study tested

The 2026 study enrolled 30 healthy adults, mostly 20–24-year-old students and staff with Fitzpatrick skin types III–IV. Everyone used one market-available batch once daily for 15 days; there was no placebo, untreated face or massage-only comparison (Kulangara et al., 2026).

The study protocol was unusually specific: 3–5 drops, five minutes of massage, 15 minutes left on, then a green-gram powder wash. Those details describe what participants did in the study, not a recommendation for readers. Facial melanin and erythema indices changed over time, while TEWL and skin thickness did not. Hydration fluctuated, and the results section says elasticity declined over time, despite the paper’s broader “improved firmness” language (Kulangara et al., 2026).

The abstract sounds more positive than the result section (Kulangara et al., 2026). A careful summary is “short-term changes in selected measurements,” not “firmer skin.”

The eight-week pilot has the same problem

The 2025 pilot followed 30 healthy adults aged 20–60 for eight weeks using one Sitaram Ayurveda commercial preparation. Two dermatologists gave visual brightness ratings at baseline, week 4 and week 8; the authors reported 56.67% as “very significant” and 26.67% as “significant” at week 8 (Maneesha et al., 2025).

This was open-label and single-arm. There was no placebo, no untreated comparison and no objective colorimeter endpoint. All listed authors were employees or officers of Sitaram Ayurveda, and the tested oil came from that company; the paper also lists Sitaram Ayurveda as its source of support. The result is therefore useful preliminary evidence but not independent confirmation (Maneesha et al., 2025).

Saffron is not the whole answer

Kumkumadi is a mixture, and the 2026 paper’s LC-MS screen found several compounds, including safranal, berberine, palmatine, liquiritin, nuciferine, rubiadine, retinol and sesamin in its one batch (Kulangara et al., 2026). Finding a compound in an oil is not the same as proving that compound caused a visible result.

The chemistry matters too. Crocin is a glycosylated saffron carotenoid, while crocetin is its aglycone; a review treats them as related but distinct materials with different evidence and routes (Guo et al., 2021). A crocin study, a saffron extract study and a Kumkumadi oil study should stay in separate boxes.

What remains uncertain

We do not know whether results persist after stopping, whether another batch behaves the same way, or whether the visible change is larger than normal day-to-day variation. The 2026 authors explicitly call for larger randomized studies with longer follow-up, and they note the small, single-institution sample and lack of validated patient-reported outcomes (Kulangara et al., 2026).

If a product causes persistent burning, swelling or a spreading rash, stop and seek clinical advice. This page does not diagnose a pigment condition or provide a treatment protocol.

Sources

This page summarizes published research. It is not a product review or medical advice.